Recent And Upcoming FDA Advisory Committee Meetings
Executive Summary
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
You may also be interested in...
Pediatric Testosterone Therapy: Sponsors Wary Of Trials Despite PREA
Studies are unfeasible, sponsors argue in advance of US advisory committee meeting that could lead to FDA ending its waiver on requiring clinical trials in pediatric patients for new testosterone replacement therapy products.
Givaudan’s AI-Powered Myrissi Allows Scents To Be Seen, Felt, Marketed
Myrissi draws on a decade of academic research in brain imagery and AI, an odor-color database of more than 25,000 consumer tests, and a wealth of affective data to translate fragrances into color patterns and images and predict the end consumer’s emotional response. The technology is targeted for use in developing fine fragrance, beauty and home-care products and marketing campaigns.
Takeda On Continued Lookout For Assets After Recent Deals
Leading Japanese firm reports solid growth in its fiscal nine months as it hints more may be to come after recent major deals to expand the mid- to late-stage pipeline and highlights progress for some key internal assets.